Usana Health Sciences (USNA) Total Current Liabilities (2016 - 2026)
Usana Health Sciences has reported Total Current Liabilities over the past 16 years, most recently at $117.2 million for Q2 2026.
- Quarterly Total Current Liabilities fell 14.66% to $117.2 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $117.2 million through Apr 2026, down 14.66% year-over-year, with the annual reading at $128.6 million for FY2026, 7.92% down from the prior year.
- Total Current Liabilities was $117.2 million for Q2 2026 at Usana Health Sciences, down from $128.6 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $160.8 million in Q1 2022 and troughed at $103.9 million in Q2 2024.
- The 5-year median for Total Current Liabilities is $123.7 million (2022), against an average of $127.3 million.
- Year-over-year, Total Current Liabilities dropped 20.33% in 2022 and then increased 21.98% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $143.8 million in 2022, then fell by 17.37% to $118.8 million in 2023, then grew by 17.48% to $139.6 million in 2024, then fell by 15.01% to $118.7 million in 2025, then decreased by 1.2% to $117.2 million in 2026.
- Per Business Quant, the three most recent readings for USNA's Total Current Liabilities are $117.2 million (Q2 2026), $128.6 million (Q1 2026), and $118.7 million (Q3 2025).